Surgery Is Just the First Step in Lung Cancer: Why EGFR Mutation Testing Matters
Lung cancer is the second most commonly diagnosed cancer in South Korea and the leading cause of cancer mortality, making it one of the country's...
Search results for "Phase 3 clinical trial"
Daewoong Pharmaceutical Nears Completion of Phase 2 IPF Trial for Bersiporosin, Readout Set for H1 2027
Daewoong Pharmaceutical has completed patient enrollment for the global Phase 2 clinical trial of bersiporosin (DWN12088), its first-in-class...
GC Cell Administers Experimental CAR-NK Therapy at Seoul National University Hospital Following MFDS Approval
GC Cell announced on Sept. 18 that South Korea’s Ministry of Food and Drug Safety has approved the compassionate use of...
Samsung Medical Center Ranks No. 5 Globally for Cancer Care in Newsweek 2027 Assessment, Climbing to No. 12 in Respiratory Medicine
Samsung Medical Center has been named the No. 5 hospital worldwide and No. 1 in South Korea for cancer treatment,...
Medytox’s Cholic Acid Fat-Reduction Injectable Nuviju Surpasses 30,000 Vials in Cumulative Supply
Medytox announced on Sept. 18 that cumulative supply of Nuviju , the world’s first fat-reduction injectable formulated...
Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026
Yuhan Corporation has detailed the status and trial design of the ongoing Phase 1/2 clinical study for YH42946, an oral...
To Curb GLP-1 Misuse, Experts Urge Tracking Who Gets Prescribed Wegovy and Mounjaro—and Why
As the adoption of GLP-1 receptor agonist obesity medications such as Wegovy and Mounjaro accelerates, medical experts...
GC Pharma’s Homegrown mRNA Vaccine Advances to Phase 2 Trials
GC Pharma announced on the 11th that South Korea’s Ministry of Food and Drug Safety has approved its Phase 2 clinical...
“I Dream of an Ordinary Life”: Expanded Insurance Coverage Brings New Hope to Dravet Syndrome Families
“Until just before my daughter turned 2, she frequently suffered not only febrile seizures but also afebrile seizures.
Celltrion Files Phase 4 IND with FDA to Support 240 mg High-Dose Zymfentra Regimen in US
Celltrion has submitted an Investigational New Drug application to the U.S. Food and Drug Administration for a Phase 4...